Form 4: Sarepta Therapeutics CFO Ian Michael Estepan Reports Charitable Donation of Shares

Sarepta Therapeutics' Chief Financial Officer, Ian Michael Estepan, reported a charitable donation of 250 common shares on December 27, 2024.

Summary

• Ian Michael Estepan, the Chief Financial Officer of Sarepta Therapeutics, filed a Form 4 indicating a change in beneficial ownership.
• The transaction involved a donation of 250 shares of common stock on December 27, 2024.
• The shares were donated at a price of $0, indicating a charitable contribution.
• Following the transaction, Mr. Estepan beneficially owns 33,696 shares of Sarepta Therapeutics common stock.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing, not indicative of positive or negative sentiment. It simply reports a transaction.

Industry Context

Form 4 filings are routine disclosures required by the SEC for company insiders, such as officers and directors, to report changes in their beneficial ownership of company securities. This filing is a standard part of regulatory compliance and provides transparency into insider transactions.

Comparison to Industry Standards

• Form 4 filings are a standard practice for all publicly traded companies in the US, ensuring transparency of insider transactions.
• The donation of shares by an executive is not uncommon and can be part of personal financial planning or charitable giving strategies.
• The number of shares donated is relatively small compared to the total number of shares held by the CFO, which is not unusual for such transactions.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a small donation by an executive and does not affect the company's operations or financial position.

Key Dates

Keywords

Form 4, Beneficial Ownership, Sarepta Therapeutics, Ian Michael Estepan, Charitable Donation, SEC Filing, SRPT, CFO